HRES 803In Committee
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Introduced October 10, 2025
Summary
Timeline
Referred to the House Committee on Energy and Commerce.
Submitted in House
Submitted in House
See how this bill affects you
Enter your details to get a personalized impact estimate.
Check your impact